GeVIR Banner

Export Results to CSV Clear Search

Genes Fold Enrichment Color Codes
  • Gene Name, Canonical Transcript - gene identifiers from gnomAD database (Build 37)
  • GeVIR % - gene rank measured in percentiles based on Gene Variation Intolerance Ranking (GeVIR) (low values indicate more variation intolerant genes, which is also true for "LOEUF %" and "VIRLoF %"). GeVIR is a method which we developed and applied on a list of 19,361 genes to sort them based on number, length and evolutionary conservation of regions without functional variants (i.e. between two missense, loss-of-function, insertion or delition variants) in gnomAD database (version 2.0.1). Only canonical transcripts were analysed.
  • LOEUF % - gene rank measured in percentiles based gnomAD loss-of-function observed/expected upper bound fraction (LOEUF) (see Figure 1). For more information about this metric, please read "Constraint" section of MacArthur Lab blog post. If you use this metric please cite gnomAD flagship paper and use most up-to-date values from gnomAD website.

    LoF observed/expected (o/e) upper Confidence Interval (CI)

    Figure 1. Screenshot of ELN gene constraint metrics from gnomAD browser

  • VIRLoF % - gene rank measured in percentiles based on both GeVIR and gnomAD LOEUF (shows the best overall performance, see Figure 2). If you use this metric please cite both GeVIR and gnomAD flagship paper.
  • GeVIR AD, LOEUF AD, VIRLoF AD, GeVIR AR, LOEUF AR, VIRLoF AR - to help users interpret gene ranks, we calculated fold enrichment of Autosomal Dominant (AD) and Autosomal Recessive (AR) genes with known molecular basis of disorder in OMIM in a range of +-5% of gene X (see Figure 2). Statistical significant fold enrichements (Fisher Exact Test p-value < 1e-5) are shown in bold in the table. For example CDK19 gene's GeVIR % is 2.37, so examined range is from 0 (2.37-5, rounded to minimal percentile) to 7.37% (2.37+5). Genes in this range are ~4 times more often (4.05 fold enrichement) associated with AD diseases and ~4 times less often (0.25 fold enrichement) associated with AR diseases. Both enrichment of AD genes and deficiency of AR genes is statistical significant. Thus GeVIR metric adds supportive evidence that CDK19 is more likely to be associated with AD than AR disease.

    Gene Percentiles AD AR Fold Enrichment

    Figure 2. Fold Enrichment of known Autosomal Dominant (AD) and Autosomal Recessive (AR) genes of each gene in the ranked lists (GeVIR, LOEUF, VIRLoF. AD genes are enriched among top ranked genes (lowest percentiles), whereas AR genes are enriched among middle ranked genes (approximetly 35-65 percentiles). Combined metric (VIRLoF, purple) shows the best perfornance, i.e. high ranked genes are more often associated with AD than AR diseases, low ranked genes are less often associated with both AD and AR diseases.
Gene Name Canonical Transcript GeVIR % LOEUF % VIRLoF % GeVIR AD LOEUF AD VIRLoF AD GeVIR AR LOEUF AR VIRLoF AR
PSG6 ENST00000292125 95.00 91.23 95.86 0.10 0.23 0.07 0.12 0.34 0.11
MAGEC1 ENST00000285879 95.00 94.59 97.41 0.10 0.23 0.08 0.12 0.24 0.07
ZDHHC11 ENST00000283441 97.50 80.85 91.94 0.10 0.35 0.14 0.11 0.57 0.16
CD300LB ENST00000392621 98.75 83.27 93.80 0.10 0.28 0.10 0.11 0.47 0.13
ZNF595 ENST00000526473 100.00 67.01 86.68 0.10 0.53 0.30 0.14 1.24 0.33
LRRC37A2 ENST00000576629 97.49 46.30 74.81 0.10 0.73 0.39 0.11 2.05 0.66
C3orf56 ENST00000398112 98.74 98.08 99.68 0.10 0.20 0.12 0.11 0.16 0.04
GSTT2B ENST00000290765 97.49 39.24 70.68 0.10 0.70 0.43 0.11 1.64 0.88
NBPF1 ENST00000430580 99.99 57.03 81.87 0.10 0.56 0.37 0.14 1.52 0.46
MRGPRX2 ENST00000329773 98.74 99.21 99.89 0.10 0.15 0.12 0.11 0.13 0.04
ZNF763 ENST00000343949 97.48 79.79 91.51 0.10 0.35 0.15 0.11 0.62 0.18
TCEB3C ENST00000330682 99.99 99.68 99.93 0.10 0.17 0.12 0.14 0.11 0.04
WFDC11 ENST00000356562 98.73 86.59 95.42 0.10 0.24 0.08 0.11 0.40 0.11
GYPB ENST00000502664 97.48 89.92 96.47 0.10 0.25 0.07 0.11 0.37 0.08
TXNRD3NB ENST00000383572 97.47 96.51 98.96 0.10 0.22 0.10 0.11 0.19 0.04
ZNF582 ENST00000301310 98.73 86.78 95.51 0.10 0.24 0.08 0.11 0.40 0.11
RP11-347C12.3 ENST00000550538 99.98 72.69 89.46 0.10 0.47 0.18 0.14 1.04 0.24
C1orf64 ENST00000329454 97.47 91.55 97.22 0.10 0.23 0.08 0.11 0.32 0.06
SEMG1 ENST00000372781 98.72 73.65 89.29 0.10 0.52 0.19 0.11 1.03 0.25
MUC2 ENST00000441003 99.98 18.52 59.57 0.10 1.49 0.49 0.14 0.76 1.69
TRIM49 ENST00000329758 97.46 86.92 94.95 0.10 0.22 0.09 0.11 0.40 0.10
KLK2 ENST00000325321 98.72 75.69 90.25 0.10 0.44 0.16 0.11 0.89 0.22
ZNF587B ENST00000442832 97.46 89.26 96.11 0.10 0.27 0.07 0.11 0.36 0.10
C10orf67 ENST00000323327 99.97 87.29 96.36 0.10 0.22 0.07 0.14 0.41 0.09
ULBP1 ENST00000229708 98.71 80.18 92.11 0.10 0.37 0.14 0.11 0.59 0.16

Cookies disclaimer

I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.